Back to search

Poland· PL-100352380

Lactulosum Orifarm Forte

A lactulose product containing lactulosum, registered in Poland by Orifarm Healthcare A/S. The same ATC class is registered in 16 of our 19 countries.

ATC A06AD11

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLactulosum Orifarm ForteATCA06AD11REGISTER NO.PL-100352380PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Lactulose is registered in 16 of 19 countries.

Countries holding a registration under ATC A06AD11 (lactulose), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Lactulose · ATC A06AD11

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Lactulosum
Manufacturer
Orifarm Healthcare A/S
Country
Poland (PL)
ATC code
A06AD11
ATC class
Lactulose
Defined daily dose
12.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05903263900825
  • gtin
    05711313006300

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

657 interactions on record for lactulose.

Graded by severity as the source publishes them — 263 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lactulose · interactions on record

657 records

  • 263 moderate
  • 18 minor
  • 376 info

Most severe, free to view

  • CisaprideA03FA02moderate
  • OndansetronA04AA01moderate
  • GranisetronA04AA02moderate
  • DolasetronA04AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lactulose in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lactulose products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Duphalac Fruit, Lactulose Genericon
  • Belgium · Bifiteral, Duphalac
  • Bulgaria · Дуфалак, Лактулакс
  • Cyprus · Duphalac
  • Czechia · Duphalac, Lactulosa Biomedica
  • Germany · Bifiteral, Bifiteral Mit Pflaumenaroma
  • Denmark · Lactulose Orifarm, Medilax
  • Estonia · Duphalac, Duphalac Fruit
  • Spain · Duphalac, Lactulosa Lainco
  • Finland · Duphalac, Duphalac Fruit
  • France · Duphalac, Lactulose Arrow
  • United Kingdom (Northern Ireland) · Lactolax, Lactulose
  • Greece · Duphafruit, Duphalac
  • Croatia · Portalak, Portalak Efekt
  • Ireland · Brillphalac, Lactecon
  • Iceland · Medilax
  • Italy · Duphalac, Epalfen Eps
  • Lithuania · Duphalac, Duphalac Fruit
  • Luxembourg · Bifiteral, Duphalac
  • Latvia · Duphalac Fruit, Lactulose Mip
  • Malta · Duphalac, Lactulose
  • Netherlands · Duphalac, Duphalac Fruit
  • Norway · Duphalac, Duphalac Med Fruktsmak
  • Portugal · Duphalac, Duphalac Ameixa
  • Romania · Duphalac Fruit, Lactecon
  • Sweden · Duphalac, Laktulos Cooper
  • Slovenia · Prorektal
  • Slovakia · Duphalac, Lactecon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b1623299-fd41-443f-8a29-c2989cecca4b
GET /v1/drugs/b1623299-fd41-443f-8a29-c2989cecca4b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Syrop",
  "source": "urpl",
  "strength": "667 mg/ml",
  "packaging": "05903263900825 ¦ OTC ¦ Skasowane ¦ 121373\n1 butelka 150 ml\n05711313006300 ¦ OTC ¦ 145550\n1 butelka 150 ml",
  "substance": "Lactulosum 667 mg/ml",
  "common_name": "Lactulosum",
  "pl_product_id": "100352380",
  "pozwolenie_nr": "24225",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about lactulose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.